Wire
Mizuho Lifts Price Target on Amylyx Pharmaceuticals to $21 From $19, Maintains Outperform Rating
Amylyx Pharmaceuticals (AMLX) has an average rating of buy and mean price target of $23.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $15.76, Change: $-0.55, Percent Change: -3.37%
$AMLX
